These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 21126

  • 1. [Studies on monoamine oxidase. (Report 37) Effects of oxygen concentration on rat liver and brain monoamine oxidase (author's transl)].
    Nakagawa K.
    Nihon Yakurigaku Zasshi; 1977 Apr; 73(3):297-305. PubMed ID: 21126
    [Abstract] [Full Text] [Related]

  • 2. Effect of lignocaine on monoamine oxidase activity of brain and liver.
    Haque SJ, Poddar MK.
    Methods Find Exp Clin Pharmacol; 1984 Mar; 6(3):119-24. PubMed ID: 6748816
    [Abstract] [Full Text] [Related]

  • 3. [Effects of oxygen and drugs on monoamine oxidase in the dog liver].
    Kimura K.
    Nihon Yakurigaku Zasshi; 1983 Apr; 81(4):305-13. PubMed ID: 6884886
    [Abstract] [Full Text] [Related]

  • 4. N-[2-(o-iodophenoxy)ethyl]cyclopropylamine hydrochloride (LY121768), a potent and selective irreversible inhibitor of type A monoamine oxidase.
    Fuller RW, Hemrick-Luecke SK, Molloy BB.
    Biochem Pharmacol; 1983 Apr 01; 32(7):1243-9. PubMed ID: 6847714
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of rat brainstem monoamine oxidase activity by CGP 6085 A.
    Hurst JH, Kulakowski EC.
    Life Sci; 1986 Oct 20; 39(16):1471-7. PubMed ID: 2430159
    [Abstract] [Full Text] [Related]

  • 6. Influence of substrate in the inhibition of rat liver and brain monoamine oxidase.
    Fuller RW.
    Arch Int Pharmacodyn Ther; 1968 Jul 20; 174(1):32-7. PubMed ID: 4386711
    [No Abstract] [Full Text] [Related]

  • 7. Inhibition patterns of monoamine oxidase in sub-fractions of rat brain mitochondria in presence of some selective inhibitors.
    Mitra C, Guha SR.
    Biochem Pharmacol; 1979 Apr 01; 28(7):1135-7. PubMed ID: 444271
    [No Abstract] [Full Text] [Related]

  • 8. [Properties of intestinal monoamine oxidase in the rat].
    Verevkina IV, Asnina VV, Gorkin VZ.
    Vopr Med Khim; 1982 Apr 01; 28(2):88-93. PubMed ID: 7080482
    [Abstract] [Full Text] [Related]

  • 9. MD 240928 and harmaline: opposite selectivity in antagonism of the inactivation of types A and B monoamine oxidase by pargyline in mice.
    Fuller RW, Wong CJ, Hemrick-Luecke SK.
    Life Sci; 1986 Feb 03; 38(5):409-12. PubMed ID: 3945167
    [Abstract] [Full Text] [Related]

  • 10. Studies on monoamine oxidase. XVIII. Enzymic properties of placental monoamine oxidase.
    Egashira T.
    Jpn J Pharmacol; 1976 Aug 03; 26(4):493-500. PubMed ID: 12389
    [Abstract] [Full Text] [Related]

  • 11. [Evidence for existence of type A MAO in mitochondria from human placenta (author's transl)].
    Kikuchi R, Kinemuchi H.
    Nihon Yakurigaku Zasshi; 1978 Sep 03; 74(6):763-72. PubMed ID: 711033
    [Abstract] [Full Text] [Related]

  • 12. Isoelectric analysis of 3H-pargyline-labelled monoamine oxidase in rat and carp.
    Obata T, Yamanaka Y, Sho S, Kinemuchi H.
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1990 Sep 03; 96(1):91-8. PubMed ID: 1980888
    [Abstract] [Full Text] [Related]

  • 13. Molecular turnover numbers of different forms of mitochondrial monoamine oxidase in rat.
    Egashira T, Ekstedt B, Kinemuchi H, Wiberg A, Oreland L.
    Med Biol; 1976 Aug 03; 54(4):272-7. PubMed ID: 957813
    [Abstract] [Full Text] [Related]

  • 14. Effect of moclobemide on rat brain monoamine oxidase A and B: comparison with harmaline and clorgyline.
    Gerardy J.
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul 03; 18(4):793-802. PubMed ID: 7938567
    [Abstract] [Full Text] [Related]

  • 15. Enzymic and molecular characteristics of a new form of monoamine oxidase, distinct from form-A and form-B.
    Yoshino M, Obata T, Sho S, Kinemuchi H.
    Jpn J Pharmacol; 1984 Jun 03; 35(2):105-15. PubMed ID: 6748374
    [Abstract] [Full Text] [Related]

  • 16. Biochemistry and physiology of monoamine oxidase (MAO) activity in the ring dove (Streptopelia risoria). I. Characteristics of MAO activity in vitro.
    Hall TR, Lea RW, Vowles DM, Harvey S.
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1985 Jun 03; 82(2):417-22. PubMed ID: 2866915
    [Abstract] [Full Text] [Related]

  • 17. [Properties of mitochondrial monoamine oxidase isolated from rabbit brain and liver].
    Von Korff RV.
    Biokhimiia; 1977 Mar 03; 42(3):396-402. PubMed ID: 861304
    [Abstract] [Full Text] [Related]

  • 18. Some cardiovascular effects of monoamine oxidase inhibitors in unanaesthetized rats.
    Marwood JF, Huston V, Wall KT.
    Clin Exp Pharmacol Physiol; 1985 Mar 03; 12(2):161-8. PubMed ID: 3839173
    [Abstract] [Full Text] [Related]

  • 19. Different sensitivity of mitochondrial and cytosolic monoamine oxidases to in vivo but not in vitro inhibition by specific irreversible inhibitors.
    Moskvitina TA, Medvedev AE.
    Med Sci Monit; 2001 Mar 03; 7(1):17-9. PubMed ID: 11208486
    [Abstract] [Full Text] [Related]

  • 20. Selective inhibition by amiflamine of monoamine oxidase type A in rat brain, liver and duodenum.
    Ask AL.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug 03; 327(1):56-63. PubMed ID: 6493351
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.